Reversible Inhibition of Cytochrome c Oxidase by Peroxynitrite Proceeds through Ascorbate-dependent Generation of Nitric Oxide*

Maria Cecilia Barone {ddagger}, Victor M. Darley-Usmar and Paul S. Brookes §

From the Department of Pathology and Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, Alabama 35294

Received for publication, April 21, 2003 , and in revised form, May 1, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Reversible inhibition of cytochrome c oxidase (CcOX) by nitric oxide (NO•) has potential physiological roles in the regulation of mitochondrial respiration, redox signaling, and apoptosis. However peroxynitrite (ONOO), an oxidant formed from the reaction of NO• and superoxide, appears mostly detrimental to cell function. This occurs both through direct oxidant reactions and by decreasing the availability of NO• for interacting with CcOX. When isolated CcOX respires with ascorbate as a reducing substrate, the conversion of ONOO to NO• is observed. It is not known whether this can be ascribed to a direct interaction of the enzyme with ONOO. In this investigation, the role of ascorbate in this system was examined using polarographic methods to measure NO• production and CcOX activity simultaneously in both the purified enzyme and isolated mitochondria. It was found that ascorbate alone accounts for >90% of the NO• yield from ONOO in the presence or absence of purified CcOX in turnover. The yield of NO was CcOX-independent but was dependent on ascorbate and ONOO concentrations and was not affected by metal chelators. Consistent with this, the interaction of ONOO with CcOX in respiring isolated mitochondria only yielded NO• when ascorbate was also present in the incubation. These observations are discussed in the context of ONOO/ascorbate reactivity and the interaction of CcOX with reactive nitrogen species.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Nitric oxide (NO•),1 endogenously produced by the NO•-synthase family of enzymes, is thought to modulate mitochondrial respiration by reversibly inhibiting complex IV, cytochrome c oxidase (CcOX) (1, 2). This interaction has been suggested to play a key role in both mitochondrial physiology and intracellular redox signaling (2). However, prolonged exposure of mitochondria to NO• results in irreversible damage to several mitochondrial proteins (complexes I, II, IV, V, aconitase, manganese superoxide dismutase) and these changes are likely to contribute to its cytotoxicity (3). These deleterious effects have been attributed to peroxynitrite (ONOO), which is produced by the reaction between NO• and superoxide (), the latter reported to be generated in substantial amounts within mitochondria (3). Indeed, several studies have shown that direct addition of ONOO to mitochondria results in inhibition of the same mitochondrial proteins as inhibited by long term NO• exposure (3, 4). Direct or indirect scavenging of ONOO in the mitochondrion by intracellular antioxidants such as glutathione is, therefore, of critical importance to NO• biology and could control the balance between physiological and pathological effects of reactive nitrogen species in the organelle (5).

Besides the ubiquitous cellular defenses against oxidative stress such as superoxide dismutase and glutathione (4, 5), CcOX has recently been proposed to contribute to the antioxidant defenses of mitochondria by directly scavenging ONOO (68). Studies performed on purified CcOX have shown that the enzyme in turnover may represent a significant sink for ONOO (68). The detailed mechanisms are not entirely clear with one study indicating a catalytic production of NO• from the interaction of ONOO with the enzyme (6) and other studies suggesting a peroxynitrite reductase activity in CcOX with the product being nitrite (7, 8). Furthermore, it has been suggested that NO• can be oxidized to nitrite by CcOX directly (9, 10) or by oxygen in a reaction that is accelerated in the lipid bilayer of mitochondrial membranes (11, 12). The suggestion that CcOX can metabolize ONOO is in agreement with other studies showing that some hemeproteins and synthetic iron-porphyrin complexes can scavenge this highly reactive species (see Refs. 13 and 14 for recent reports).

Despite these observations, the potential interaction of ONOO with the high concentrations of reductants used to assess purified CcOX activity has not been defined (68). Specifically ascorbate, a ubiquitous antioxidant, is used in some of these studies at millimolar concentrations. This is potentially important because ascorbate has been shown to increase NO• bioavailability in blood vessels, an effect which may be mediated by enhanced synthesis of NO• and/or by prevention of its breakdown (15). In the mitochondrion the role of ascorbate is unknown, but its concentration in the mitochondrial matrix has been estimated in the low millimolar range.2 Moreover, Li et al. (16) have recently proposed that the mitochondrial respiratory chain can recycle ascorbate from its oxidized form (DHA) to the reduced form. In this study, we investigated the possible contribution of ascorbate to the release of NO• from ONOO in the presence and absence of CcOX using both the purified enzyme and isolated mitochondria.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
All biochemicals were from Sigma unless otherwise specified. Solutions of ONOO were prepared in 0.5 M NaOH according to Reed et al. (17) and stored at –80 °C, and their concentrations were spectrophoto-metrically determined just before use ({epsilon}302 = 1670 M1 cm1 (18)). Concentrated stock solutions (typically ~150 mM) were diluted to 10 mM in water on the day of the experiment. Solutions of (+)-sodium L-ascorbate were freshly prepared daily. Bovine heart CcOX was purified according to Yonetani (19) and stored in 0.1 M K+ phosphate buffer, 0.5% (w/v) lauryl maltoside, 0.1 mM EDTA, pH 7.3, at –80 °C. Concentration is expressed in functional units (cytochrome-aa3, {Delta}{epsilon}445 red-ox = 156 mM1 cm1). Rat liver mitochondria were prepared as described by Rickwood et al. (20). Nitric oxide solutions were obtained by equilibrating degassed water with pure NO• gas (21), and their concentrations were determined with an NO• electrode (see next paragraph).

Polarographic measurements (21) were performed in a thermostated chamber equipped with electrodes for oxygen and NO• (Instech, Plymouth Meeting, PA and WPI, Sarasota, FL, respectively). The NO• electrode was calibrated using the acidified nitrite/potassium iodide method as recommended by the supplier (World Precision Instruments, Inc., Sarasota, FL). In experimental traces, a known amount of authentic NO• (from the calibrated stock solution) was always added at the end to quantify the amount of NO• generated in the experiment. Data were digitally recorded and analyzed with Windaq software (Dataq Instruments, Inc., Akron, OH). Unless otherwise stated, all isolated CcOX incubations were performed at 20 °C in 25 mM K+ phosphate buffer, pH 7.3, with 0.1% w/v lauryl maltoside. Isolated mitochondrial incubations were performed in respiration medium comprising KCl (100 mM), sucrose (25 mM), HEPES (10 mM), MgCl2 (5 mM), KH2PO4 (5 mM), EGTA (1 mM), pH 7.3, at 37 °C. Errors are expressed as standard deviations of at least three independent experiments unless otherwise specified. Statistical significance was assessed with an unpaired Student's t test and a p value < 0.05.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The ability of CcOX to catalyze the conversion of ONOO to NO• was investigated using both the purified enzyme and isolated mitochondria. As shown in Fig. 1A, purified CcOX was incubated in the presence of ascorbate, TMPD, and cytochrome c in air-equilibrated buffer at 20 °C. This temperature was selected to maintain the activity of the purified enzyme during the course of the experiment. Both O2 consumption and NO• were recorded. Upon addition of ONOO, release of NO• and inhibition of CcOX activity were observed as being consistent with previous observations (6). Following aerobic decomposition of NO• from the solution, the enzymatic activity recovered almost completely. For comparison, Fig. 1A also shows the effects of authentic NO• on CcOX in turnover under the same conditions. In both cases CcOX inhibition occurred almost instantaneously upon appearance of NO• in the solution, although recovery of activity did not occur until well after disappearance of NO• from the solution consistent with the slow dissociation rate of NO• from CcOX at this temperature (9). The percentage recovery from inhibition was similar for ONOO and NO• with an ~10% irreversible component for ONOO, although this was not statistically significant (p = 0.186; Fig. 1B). The observation that NO• produced from ONOO leads to the same inhibition of CcOX as seen with authentic NO• provides further functional evidence that NO• is produced from ONOO.



View larger version (21K):
[in this window]
[in a new window]
 
FIG. 1.
Ascorbate, not CcOX in turnover, releases NO• from ONOO A, typical set of O2/NO• electrode traces showing the effects of adding ONOO (50 µM) or authentic NO• (2.3 µM) to purified CcOX (20 nM) respiring in the presence of reductants ascorbate (20 mM), TMPD (0.5 mM), cytochrome c (20 µM). B, recovery of CcOX activity after inhibition by authentic NO• or that originating from ONOO. Values are expressed as percentage of the activity measured before addition of NO• or ONOO. C, typical NO• electrode traces observed when ascorbate, TMPD, or cytochrome c2+ alone were allowed to react with ONOO in the absence of CcOX (same buffer and concentrations as above). D, quantitation of data from A and C comparing NO• released from ONOO in the presence of CcOX in turnover (i.e. ascorbate TMPD cytochrome c CcOX) and ascorbate alone. E, typical set of O2/NO• electrode traces showing the effects of adding ONOO (100 µM) or authentic NO• (2.5 µM) to mitochondria (1 mg of protein/ml) respiring on glutamate (5 mM), malate (2.5 mM), and ADP (1 mM). Traces: (i), no ascorbate present and ONOO added; (ii), with ascorbate (1 mM) and ONOO added; (iii), with ascorbate (1 mM) and NO• added.

 

To assess the role of CcOX in the production of NO• from ONOO, we added ONOO to ascorbate, TMPD, or cytochrome c2+ alone under the same conditions as described previously. As Fig. 1C shows, addition of ONOO to ascorbate produced a significant amount of NO• comparable with that observed when ONOO was added to CcOX in turnover (2.0 ± 0.02 versus 2.4 ± 0.13 µM; quantified in Fig. 1D). This suggests that ascorbate, not CcOX, is mainly responsible for the NO• generation seen in Fig. 1A. The concentration of ascorbate in the cytosol (22, 23) and the reported ascorbate levels in the mitochondrial matrix (see the Introduction) suggest that this mechanism of NO• generation from ONOO may be relevant to mitochondrial physiology.

However, these data do not preclude the possibility that CcOX alone may contribute to the NO• generation from ONOO. To test this, we examined isolated mitochondria respiring in the presence of glutamate, malate, and ADP (Fig. 1E). In this system, electrons are delivered to CcOX through the respiratory chain (complex I ubiquinone complex III cytochrome c complex IV), thus reducing substrates such as ascorbate are not required. Addition of ONOO to respiring mitochondria resulted in neither NO• generation nor inhibition of respiration. However, in the presence of 1 mM ascorbate NO• was produced and consequently respiration was inhibited. The effect of authentic NO• on mitochondrial respiration is also shown further suggesting that the inhibition of respiration caused by ONOO is due to NO•.

Taken together, the data in Fig. 1 show that at 50–100 µM ONOO, CcOX does not catalyze the reduction of ONOO to NO•, whereas ascorbate does. However, the concentrations of ascorbate used in the experiments described above are either nonphysiological (20 mM) or in the high intracellular physiological range (1 mM) (22, 23). To further investigate the ability of ascorbate to release NO• from ONOO, we measured NO• production at different concentrations of ascorbate and ONOO. Fig. 2A shows that ONOO addition to phosphate buffer at neutral pH did not result in significant release of NO•. Even upon subsequent addition of ascorbate, NO• was not produced, thus ruling out the possibility of NO• generation from a reaction between ascorbate and the products of ONOO decomposition, and (24). However, when ONOO was added again to the chamber in the presence of ascorbate (50 µM), a transient production of NO• was observed. The height of the NO• peak was proportional to the concentration of ONOO in the range 10–100 µM and to the concentration of ascorbate up to 1 mM (Fig. 2, B and C). However, above 1 mM ascorbate, the generation of NO• reaches a plateau. The saturation kinetics in the supra-millimolar range suggest that the production of NO• does not occur through a direct reaction between ONOO and ascorbate but through a more complex mechanism.



View larger version (21K):
[in this window]
[in a new window]
 
FIG. 2.
Physiological levels of ascorbate can generate NO• from ONOO A, typical NO• electrode trace showing sequential addition of ONOO (50 µM), ascorbate (50 µM), ONOO (50 µM), authentic NO• (0.9 µM followed by 1.8 µM). B and C, dose-response curves for ascorbate and ONOO, respectively, from the type of experiments shown in A. Data are means ± S.D. of 3 x 20 °C and 2 x 37 °C independent measurements.

 

To provide further insight to the NO• production by ONOO and ascorbate, we studied the yield of NO• under different conditions (Fig. 3). Because the reactivity of both ascorbate and ONOO might be affected by even trace catalytic amounts of transition metals, we performed the same experiment described in Fig. 2A, in the presence of the metal chelators, neocuproine, EDTA, or DTPA (Fig. 3, A and B). The peak height of NO• generated was not decreased significantly by neocuproine or DTPA and only slightly by EDTA (~10% less NO• versus control, p = 0.003). Interestingly, DTPA increased NO• stability, as measured by the slope of the decomposition curve for NO•, by ~5-fold compared with control (p = 0.04).



View larger version (23K):
[in this window]
[in a new window]
 
FIG. 3.
Effects of metal chelators, CO2, superoxide dismutase (SOD), and pH on ascorbate-driven release of NOfrom ONOO A, typical NO• electrode traces; ONOO (50 µM) was added to ascorbate (5 mM) in the presence of either neocuproine (100 µM), EDTA (100 µM), or DTPA (100 µM). B, quantitation of the NO• produced from several experiments of the type shown in A. C, quantitation of NO• generated from the addition of ONOO (50 µM) to ascorbate (5 mM) alone, DHA (5 mM) alone, or ascorbate (5 mM) plus either NaHCO3 (25 mM) or superoxide dismutase (200 units/ml). D, release of NO• following addition of ONOO (50 µM) to ascorbate (5 mM) at pH 6.0, 7.3, or 8.0. Data are means ± S.D. (n = 3). Error bars are within size of symbols.

 

To determine whether the generation of NO• from ascorbate plus ONOO requires the reduced form of ascorbate, we studied the interaction of ONOO with DHA, the oxidized form where one of the hydroxyl groups of ascorbate is replaced by a carbonyl. Fig. 3C shows that although a small amount of NO• is still generated (~5% of control), the reaction yield is significantly reduced suggesting that ascorbate must act as a reductant for this reaction to occur.

The effects of NaHCO3 and superoxide dismutase are also shown in Fig. 3C. These data show that generation of NO• from ascorbate plus ONOO is abrogated by the presence of NaHCO3. In contrast, superoxide dismutase enhanced the generation of NO• by a small but significant amount (p = 0.043). Because the stability of ONOO is affected by several factors, including the equilibrium with its protonated form (ONOOH, pKa ~ 6.8), we also studied the effect of pH on the amount of NO• produced (Fig. 3D). A decrease in the yield of the reaction was observed with decreasing pH.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In this study, it has been shown that physiological concentrations of ascorbate can mediate the release of NO• from ONOO. This result has implications not only for the physiologic scavenging of ONOO but also for interpretation of the interactions of this reactive nitrogen species with CcOX (68). The peroxynitrite-reductase activity of CcOX results in the formation of nitrite as shown in a recent study (7), and this pathway is likely to be contributing to the metabolism of ONOO in this system. However, an additional process is required to explain the production of NO• observed in the present study. The data presented herein suggest that the majority of NO• release from CcOX in turnover can be accounted for by the presence of ascorbate in the reaction mixture. This is in contrast to the results of Sharpe and Cooper (6) who report that CcOX in turnover is required for NO• generation from ONOO and that little or no NO• is generated in the absence of the enzyme. However, several differences between the experimental systems may account for this discrepancy. For example, the temperatures are different (20 °C here versus 30 °C in Sharpe and Cooper (6)), and HEPES was a constituent of the buffer in Sharpe and Cooper (6). The use of HEPES was avoided in this study because it has been shown that it can react with ONOO to form a labile NO• donor (5, 25, and acknowledged in Ref. 7). In addition, it is possible that the reaction that yields NO• from ONOO is enhanced by the ascorbyl radical (), which in turn is produced by auto-oxidation of ascorbate under aerobic conditions. In this case, the formation of NO• from ascorbate plus ONOO would be accelerated in the presence of any system that enhances ascorbate oxidation including the TMPD cytochrome c CcOX system. This may explain the slightly greater generation of NO• observed with CcOX versus ascorbate alone (Fig. 1E). In addition, this may underlie the dependence of NO• generation on CcOX turnover rate as reported for un-coupled versus coupled CcOX vesicles (6), because a greater CcOX turnover would equate to greater oxidation of ascorbate and, thus, more .

In considering a possible mechanism for the formation of NO• from ascorbate plus ONOO, the data in Fig. 3 are of particular importance. First, the observation that less NO• is made at acidic pH suggests that the source of NO• is ONOO rather than ONOOH (pKa ~ 6.8). This is consistent with the observation that NaHCO3 abolished NO• formation in this system, because it is known that CO2 can react with ONOO but not ONOOH (26).

Several mechanisms may exist for the generation of NO• from ONOO. For example, it is possible that ascorbate or one of its derivatives (e.g. ) may react with ONOO to form an intermediate that is an NO• donor, as previously shown, for low-molecular weight compounds such as HEPES and glutathione (5, 25). However, the rapid appearance of NO• in the medium following ONOO addition (see Figs. 1, 2, 3) suggests that any such intermediate would have a very short half-life so that both are made and degraded within the response time of the NO• electrode. In addition, because the decomposition of certain NO• donors is accelerated in the presence of metals, the lack of an effect of metal chelators on NO• generation (Fig. 3A) suggests this is not a significant pathway.

Another possible mechanism for NO• generation from ONOO could be the scavenging of by the ascorbate system (ascorbate plus ). This would serve to drive the equilibrium (NO• + ONOO) to the left. Literature evidence to date has concentrated on the diffusion-limited forward reaction between NO• and to yield ONOO. However, a significant back-reaction does exist (k = 0.02 s1 at 25 °C) and could be enhanced in the presence of a sink for (27). In this regard, Jackson et al. (28) have shown that ascorbate can effectively scavenge and compete with NO• for reaction with , although only at concentrations in the high millimolar range (28). Notably, the reaction between and is ~1000x faster than that between ascorbate and (k = 2.3 x 108 M–1 s–1 versus 3 x 105 M–1 s1, respectively) (29, 30). Thus, in a system where ascorbate oxidation is enhanced (e.g. CcOX in turnover), scavenging may be enhanced because of greater formation of (see above). Such enhancement may decrease into the physiological range the effective concentration of ascorbate required for such scavenging. In support of a role for scavenging by ascorbate, Fig. 3 shows that superoxide dismutase can mildly enhance NO• formation in this system. However this effect appears small, because this experiment was performed at 5 mM ascorbate at which point scavenging may have already been saturated (see concentration dependence, Fig. 2B).

Additional mechanisms for the ascorbate-driven generation of NO• from ONOO may be hypothesized including reactions between ascorbate/ and other known decomposition products of ONOO (e.g. , OH•, (27, 31)). However, it is not yet clear whether any of these reactions would yield NO•.

Figs. 1, 2, 3 suggest an ~2% yield of NO• from ONOO. In a physiologic context, where ONOO must have come from NO• originally, this raises the question whether this reaction is a significant pathway for the regeneration of NO•. However, given that soluble guanylate cyclase and cytochrome c oxidase are sensitive to low nanomolar concentrations of NO• and that cell signaling is amplified at these enzymes, biological responses are plausible. Moreover, it does appear that ascorbate can act as an antioxidant for the prevention of ONOO formation (28), thus increasing NO• availability.

In the context of the mitochondrion, the organelle has been proposed as a potential source of ONOO (32). A significant store of ~1 mM ascorbate is proposed to exist in the matrix (see Introduction), and thus ascorbate-driven ONOO decomposition may occur in this organelle. Whereas the data in Fig. 1 do not show NO• generation from ONOO in mitochondria, it is unclear whether ascorbate survived the mitochondrial isolation procedure and, if so, what its redox state was, because DHA does not catalyze NO• release from ONOO (Fig. 3C). Overall, water-soluble antioxidants such as glutathione (5) and ascorbate may comprise the primary mitochondrial defense against ONOO. This raises the possibility that only ONOO made in situ may be damaging to the organelle. Furthermore, the ability of CO2 to modulate ascorbate-driven ONOO degradation (Fig. 3) is unique from a mitochondrial perspective, because the organelle is a major cellular source of CO2. Protein tyrosine nitration mediated by ONOO is enhanced by CO2, thus raising the possibility of modulation of this post-translational modification by ascorbate of mitochondrial proteins.

Whereas it is unlikely that the ascorbate plus ONOO reaction represents a significant source of NO•, it is the balance between these reactive nitrogen species that is important for cellular function. Therefore, these results have implications for the role of mitochondria and reactive nitrogen species in processes such as apoptosis, because it has been shown that NO• can prevent cytochrome c release from mitochondria, whereas ONOO enhances it (33, 34). Thus, ascorbate may act as a modulator of mitochondrial apoptotic signaling as has previously been proposed for glutathione (31).

In summary, we have shown that the generation of NO• from ONOO by CcOX in turnover is most likely because of ascorbate, and it appears that, whereas CcOX does possess a ONOO reductase activity (7), this is not the primary source of NO• in this system. Further studies are required to elucidate the precise roles of and the scavenging of in this system.


    FOOTNOTES
 
* This study was supported in part by National Institutes of Health Grant RO1-AA13395 (to V. D. U.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} Supported by the Ministero dell'Istruzione, dell'Universitá e della Ricerca of Italy (Programma di Ricerca Scientifica Interuniversitario Nazionale "Bioenergetica: aspetti genetici, biochimici e fisiopatologici"). Present address: Dept. of Biochemical Sciences, University of Rome "La Sapienza," Rome I-00185, Italy. Back

§ Supported by the American Heart Association and the University of Alabama, Birmingham, Clinical Nutrition Research Center. To whom correspondence should be addressed: Dept. of Pathology, University of Alabama, Rm. 329, BMR-2, 901 19th St. South, Birmingham, AL 35294. Tel.: 205-975-9507; Fax: 205-934-7447; E-mail: brookes{at}uab.edu.

1 The abbreviations used are: NO•, nitric oxide; ONOO, peroxynitrite; , ascorbyl radical; CcOX, cytochrome c oxidase; DHA, dehydroascorbate; DTPA, diethylenetriaminepentaacetic acid; , superoxide anion; TMPD, N,N,N',N'-tetramethyl-p-phenylenediamine. Back

2 T. M. Hagen, personal communication. Back


    ACKNOWLEDGMENTS
 
We thank Paolo Sarti (Rome, Italy), Jack R. Lancaster, Jr., and Rakesh Patel (University of Alabama at Birmingham) for insightful discussions.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Sarti, P., Giuffrè, A., Barone, M. C., Forte, E., Mastronicola, D., and Brunori, M. (2003) Free Radic. Biol. Med. 34, 509–520[CrossRef][Medline] [Order article via Infotrieve]
  2. Brookes, P. S., Levonen, A. L., Shiva, S., Sarti, P., and Darley-Usmar, V. M. (2002) Free Radic. Biol. Med. 33, 755–764[CrossRef][Medline] [Order article via Infotrieve]
  3. Radi, R., Cassina, A., and Hodara, R. (2002) Biol. Chem. Hoppe-Seyler 383, 401–409
  4. Radi, R., Cassina, A., Hodara, R., Quijano, C., and Castro, L. (2002) Free Radic. Biol. Med. 33, 1451–1464[CrossRef][Medline] [Order article via Infotrieve]
  5. Lizasoain, I., Moro, M. A., Knowles, R. G., Darley-Usmar, V., and Moncada, S. (1996) Biochem. J. 314, 877–880[Medline] [Order article via Infotrieve]
  6. Sharpe, M. A., and Cooper, C. E. (1998) J. Biol. Chem. 273, 30961–30972[Abstract/Free Full Text]
  7. Pearce, L. L., Pitt, B. R., and Peterson, J. (1999) J. Biol. Chem. 274, 35763–35767[Abstract/Free Full Text]
  8. Pearce, L. L., Kanai, A. J., Birder, L. A., Pitt, B. R., and Peterson, J. (2002) J. Biol. Chem. 277, 13556–13562[Abstract/Free Full Text]
  9. Sarti, P., Giuffrè, A., Forte, E., Mastronicola, D., Barone, M. C., and Brunori, M. (2000) Biochem. Biophys. Res. Commun. 274, 183–187[CrossRef][Medline] [Order article via Infotrieve]
  10. Torres, J., Sharpe, M. A., Rosquist, A., Cooper, C. E., and Wilson, M. T. (2000) FEBS Lett. 475, 263–266[CrossRef][Medline] [Order article via Infotrieve]
  11. Liu, X., Miller, M. J. S., Joshi, M. S., Thomas, D. D., and Lancaster, J. R., Jr. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 2175–2179[Abstract/Free Full Text]
  12. Shiva, S., Brookes, P. S., Patel, R. P., Anderson, P. G., and Darley-Usmar, V. M. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 7212–7217[Abstract/Free Full Text]
  13. Jensen, M. P., and Riley, D. P. (2002) J. Biol. Inorg. Chem. 41, 4788–4797
  14. Herold, S., Shivashankar, K., and Mehl, M. (2002) Biochemistry 41, 13460–13472[CrossRef][Medline] [Order article via Infotrieve]
  15. May, J. M. (2000) Free Radic. Biol. Med. 28, 1421–1429[CrossRef][Medline] [Order article via Infotrieve]
  16. Li, X., Cobb, C. E., and May, J. M. (2002) Arch. Biochem. Biophys. 403, 103–110[Medline] [Order article via Infotrieve]
  17. Reed, J. W., Ho, H. H., and Jolly, W. L. (1974) J. Am. Chem. Soc. 96, 1248–1249
  18. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., and Freeman, B. A. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 1620–1624[Abstract]
  19. Yonetani, T. (1963) J. Biol. Chem. 235, 845–852
  20. Rickwood, D., Wilson, M. T., and Darley-Usmar, V. M. (1987) in Mitochondria, A Practical Approach (Darley-Usmar, V. M., Rickwood, D., and Wilson, M. T., eds) pp. 3–5, IRL Press, Oxford
  21. Brookes, P. S., Shiva, S., Patel, R. P., and Darley-Usmar, V. M. (2002) Methods Enzymol. 359, 305–319[Medline] [Order article via Infotrieve]
  22. Slade, R., Stead, A. G., Graham, J. A., and Hatch, G. E. (1985) Am. Rev. Respir. Dis. 131, 742–746[Medline] [Order article via Infotrieve]
  23. Washko, P., Rotrosen, D., and Levine, M. (1989) J. Biol. Chem. 264, 18996–19002[Abstract/Free Full Text]
  24. Kissner, R., and Koppenol, W. H. (2002) J. Am. Chem. Soc. 124, 234–239[Medline] [Order article via Infotrieve]
  25. Schmidt, K., Pfeiffer, S., and Mayer, B. (1998) Free Radic. Biol. Med. 24, 859–886[CrossRef][Medline] [Order article via Infotrieve]
  26. Merenyi, G., and Lind, J. (1997) Chem. Res. Toxicol. 10, 1216–1220[CrossRef][Medline] [Order article via Infotrieve]
  27. Goldstein, S., Czapski, G., Lind, J., and Merenyi, G. (2001) Chem. Res. Toxicol. 14, 657–660[Medline] [Order article via Infotrieve]
  28. Jackson, T. S., Xu, A., Vita, J. A., and Keaney, J. F. (1998) Circ. Res. 83, 916–922[Abstract/Free Full Text]
  29. Scarpa, M., Stevanato, R., Viglino, P., and Rigo, A. (1983) J. Biol. Chem. 258, 6695–6697[Abstract/Free Full Text]
  30. Nishikimi, M. (1975) Biochem. Biophys. Res. Commun. 63, 463–468[Medline] [Order article via Infotrieve]
  31. Hancock, J. T., Desikan, R., and Neill, S. J. (2001) Free Radic. Biol. Med. 31, 697–703[CrossRef][Medline] [Order article via Infotrieve]
  32. Packer, M. A., Porteous, C. M., and Murphy, M. P. (1996) Biochem. Mol. Biol. Int. 40, 527–534[Medline] [Order article via Infotrieve]
  33. Brookes, P. S., Padilla Salinas, E., Darley-Usmar, K., Eiserich, J. P., Freeman, B. A., Darley-Usmar, V. M., and Anderson, P. G. (2000) J. Biol. Chem. 275, 20474–20479[Abstract/Free Full Text]
  34. Packer, M. A., and Murphy, M. P. (1994) FEBS Lett. 345, 237–240[CrossRef][Medline] [Order article via Infotrieve]